NCT05127447

Brief Summary

The aim of this study is to investigate effects of external electric stimulating in individuals with urinary incontinence after prostatectomy.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2021

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 17, 2021

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 19, 2021

Completed
12 days until next milestone

Study Start

First participant enrolled

December 1, 2021

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2022

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
Last Updated

November 19, 2021

Status Verified

November 1, 2021

Enrollment Period

7 months

First QC Date

November 17, 2021

Last Update Submit

November 17, 2021

Conditions

Outcome Measures

Primary Outcomes (2)

  • Pad Test

    A 1-hour pad test will be applied. Beginning with an empty bladder, a pre-weighed sanitary napkin will be inserted into the underwear. The patient will be asked to drink 500 ml of water within 15 minutes and then remain active for half an hour. Then, various activities will be made to the patient to provoke involuntary urine leakage with a full bladder. weight will be measured.

    change from baseline at 8 weeks

  • UI symptoms

    The ICIQ\_SF is a UI questionnaire that evaluates symptom type and severity. It consists of 6 questions in total and the total score is 3., 4., 5. It is obtained by adding the scores they get from the questions

    change from baseline at 8 weeks

Secondary Outcomes (4)

  • Life quality

    change from baseline at 8 weeks

  • Sexual Function

    change from baseline at 8 weeks

  • Evaluation of Subjective Improvement Perception

    after treatment (8th week)

  • Evaluation of Treatment Satisfaction

    after treatment (8th week)

Study Arms (2)

ES group

EXPERIMENTAL

External neuromuscular electrical stimulation was applied to the patients in supine position. It was applied for 30 minutes 3 days a week for 8 weeks. This stimulation consists of a total of eight external electrodes, including 2 sheaths wrapped around the thigh area and 4 electrodes for each leg. Electrodes were placed on the anterior and posterior proximal thighs, buttocks, and outside of the hips. The treatment protocol was applied with symmetrical biphasic current at a frequency of 50 Hertz (Hz), with stimulation and rest periods of 5 seconds of contraction and 5 seconds of rest.

Device: ES application

Sham group

SHAM COMPARATOR

In the Sham group, for 45 minutes, 2 days a week, a vacuum electrode was connected from combined vacuum electrotherapy device over the pelvis and thigh, and only vacuum was applied while the patient was in the supine position, and no current was given from the applied device.

Other: Sham application

Interventions

Electrical stimulation (ES) application will be given to the ES group

ES group

Only vacuum was applied and no current was given from the applied device

Sham group

Eligibility Criteria

Age40 Years+
Sexmale(Gender-based eligibility)
Gender Eligibility DetailsParticipants with post-prostatectomy urinary incontinence
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Being a male individual with stress or stress-dominant mixed UI symptoms after undergoing prostatectomy surgery for prostate cancer in the urology clinic
  • Being over 40 years old
  • Being 24 and over with Mini Mental Test results in individuals over 65 years of age.
  • Not having residual cancerous tissue
  • Volunteering to participate in the study

You may not qualify if:

  • Having serious cardiovascular disease (unstable angina and arrhythmia patients, heart failure patients, etc.)
  • Having sensory loss
  • Having an ongoing urinary infection
  • Having only urgency urinary incontinence
  • Using a pacemaker
  • Receiving active cancer treatment (radiotherapy, chemotherapy)
  • Lack of evaluation parameters
  • Not continuing the treatment regularly

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Urinary Incontinence

Condition Hierarchy (Ancestors)

Urination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Seyda Toprak Celenay

    Ankara Yildirim Beyazıt University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Seyda Toprak Celenay

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomly divided into two groups (such as ES and sham groups)
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
associate professor

Study Record Dates

First Submitted

November 17, 2021

First Posted

November 19, 2021

Study Start

December 1, 2021

Primary Completion

July 1, 2022

Study Completion

December 1, 2022

Last Updated

November 19, 2021

Record last verified: 2021-11